← Back to Clinical Trials
Recruiting NCT07488936

NCT07488936 Effects of Low Back Pain Types on Pain Severity and Quality of Life in Patients With Failed Back Surgery Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07488936
Status Recruiting
Phase
Sponsor Konya Beyhekim Training and Research Hospital
Condition Failed Back Surgery Syndrome
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2025-12-01
Primary Completion 2025-12-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2025-12-01 with a primary completion date of 2025-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to determine the effects of different types of low back pain on pain intensity and quality of life in patients with failed low back surgery syndrome. The study will include 200 patients with failed lumbar spine surgery syndrome who present to the physical therapy and rehabilitation (FTR) outpatient clinics of Konya Beyhekim Training and Research Hospital with complaints of lower back pain lasting at least 3 months. Patients will be evaluated in a single session. The Visual Analog Scale (VAS), Pain Catastrophizing Scale (PCS) will be used to determine the patients' pain level and impact, the Roland-Morris Disability Questionnaire (RMDQ) will be used for functionality assessment, and the SF-36 score will be used for quality of life assessment. To determine the type of pain: Those with pain levels above the cutoff value on the DN4 (Douleur Neuropathique 4 Questions) pain scale will be diagnosed with neuropathic pain. For nociplastic pain affecting the musculoskeletal system, a diagnosis of nociplastic pain will be made according to clinical criteria and grading scores. Those who do not meet these criteria will be classified as having nociceptive pain.

Eligibility Criteria

Inclusion Criteria: * \*Being over 18 years of age * Being willing to participate in the study * Having been diagnosed with failed back surgery syndrome Exclusion Criteria: * \*Those under 18 years of age * Those with major psychiatric illnesses * Those with communication problems * Other causes of back pain

Contact & Investigator

Central Contact

emrah çetin, doctor

✉ dremrahcetin4547@gmail.com

📞 +905417606950

Principal Investigator

savaş KARPUZ, ASSOCIATE PROFESSOR DOCTOR

STUDY DIRECTOR

KONYA BEYHEKİM EĞİTİM ARAŞTIRMA HASTANESİ

Frequently Asked Questions

Who can join the NCT07488936 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Failed Back Surgery Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07488936 currently recruiting?

Yes, NCT07488936 is actively recruiting participants. Contact the research team at dremrahcetin4547@gmail.com for enrollment information.

Where is the NCT07488936 trial being conducted?

This trial is being conducted at Konya, Turkey (Türkiye).

Who is sponsoring the NCT07488936 clinical trial?

NCT07488936 is sponsored by Konya Beyhekim Training and Research Hospital. The principal investigator is savaş KARPUZ, ASSOCIATE PROFESSOR DOCTOR at KONYA BEYHEKİM EĞİTİM ARAŞTIRMA HASTANESİ. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology